Cosmos Health Boosts Buyback Total to 3.87 Million Shares

The latest acquisition was executed in the open market at an average price of 25.39 cents per share. This brings the cumulative expenditure for the buyback initiative to approximately $758,000, leaving significant capacity remaining within the board's $5 million authorization. The company maintains that it will continue these purchases opportunistically, contingent on evolving market conditions through the program's December 31, 2026 expiration date.

Chief Executive Greg Siokas defended the strategy, citing a firm conviction that the current market valuation fails to capture the underlying strength of the company’s platform. Despite the buyback effort, investor sentiment remains cautious as the stock recently dipped another 5%. The firm retains flexibility to execute future transactions through private negotiations or standard open-market methods, provided the activity aligns with its long-term business trajectory.